HEADER APOPTOSIS 09-DEC-08 2KBW TITLE SOLUTION STRUCTURE OF HUMAN MCL-1 COMPLEXED WITH HUMAN BID_BH3 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL- COMPND 3 1; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: RESIDUES 167-326; COMPND 6 SYNONYM: BCL-2-RELATED PROTEIN EAT/MCL1, MCL1/EAT; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: BH3-INTERACTING DOMAIN DEATH AGONIST; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: BH3 MOTIF, RESIDUES 76-106; COMPND 12 SYNONYM: P22 BID, BID, BH3-INTERACTING DOMAIN DEATH AGONIST P15, P15 COMPND 13 BID, BH3-INTERACTING DOMAIN DEATH AGONIST P13, P13 BID, BH3- COMPND 14 INTERACTING DOMAIN DEATH AGONIST P11, P11 BID; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MCL1, MYELOID CELL LEUKEMIA 1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET32A; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: BID; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 17 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 18 EXPRESSION_SYSTEM_VECTOR: PGEX-6P1 KEYWDS MCL-1, BID_BH3, COMPLEX, ALTERNATIVE SPLICING, APOPTOSIS, CYTOPLASM, KEYWDS 2 DEVELOPMENTAL PROTEIN, DIFFERENTIATION, MEMBRANE, MITOCHONDRION, KEYWDS 3 NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL KEYWDS 4 CONJUGATION EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR Q.LIU,T.MOLDOVEANU,T.SPRULES,E.MATTA-CAMACHO,N.MANSUR-AZZAM,K.GEHRING REVDAT 4 16-MAR-22 2KBW 1 REMARK REVDAT 3 30-JUN-10 2KBW 1 JRNL REVDAT 2 28-APR-10 2KBW 1 JRNL REVDAT 1 15-DEC-09 2KBW 0 JRNL AUTH Q.LIU,T.MOLDOVEANU,T.SPRULES,E.MATTA-CAMACHO,N.MANSUR-AZZAM, JRNL AUTH 2 K.GEHRING JRNL TITL APOPTOTIC REGULATION BY MCL-1 THROUGH HETERODIMERIZATION. JRNL REF J.BIOL.CHEM. V. 285 19615 2010 JRNL REFN ISSN 0021-9258 JRNL PMID 20392693 JRNL DOI 10.1074/JBC.M110.105452 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NMRDRAW, CNS REMARK 3 AUTHORS : DELAGLIO, GRZESIEK, VUISTER, ZHU, PFEIFER AND BAX REMARK 3 (NMRDRAW), BRUNGER, ADAMS, CLORE, GROS, NILGES AND REMARK 3 READ (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2KBW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-DEC-08. REMARK 100 THE DEPOSITION ID IS D_1000100928. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 20 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.5 MM [U-95% 15N] MCL-1-1, 0.5 REMARK 210 MM BID_BH3-2, 20 MM HEPES-3, 1 REMARK 210 MM DTT-4, 90% H2O/10% D2O; 0.5 REMARK 210 MM MCL-1-5, 0.5 MM [U-95% 15N] REMARK 210 BID_BH3-6, 20 MM HEPES-7, 1 MM REMARK 210 DTT-8, 90% H2O/10% D2O; 0.5 MM REMARK 210 [U-95% 13C; U-95% 15N] MCL-1-9, REMARK 210 0.5 MM BID_BH3-10, 20 MM HEPES- REMARK 210 11, 1 MM DTT-12, 90% H2O/10% D2O; REMARK 210 0.5 MM [U-95% 13C; U-95% 15N] REMARK 210 MCL-1-13, 0.5 MM BID_BH3-14, 20 REMARK 210 MM HEPES-15, 1 MM DTT-16, 100 % REMARK 210 [U-100% 2H] D2O-17, 100% D2O; REMARK 210 0.5 MM MCL-1-18, 0.5 MM [U-95% REMARK 210 13C; U-95% 15N] BID_BH3-19, 20 REMARK 210 MM HEPES-20, 1 MM DTT-21, 90% REMARK 210 H2O/10% D2O; 0.5 MM MCL-1-22, REMARK 210 0.5 MM [U-95% 13C; U-95% 15N] REMARK 210 BID_BH3-23, 20 MM HEPES-24, 1 MM REMARK 210 DTT-25, 100 % [U-100% 2H] D2O-26, REMARK 210 100% D2O; 0.4 MM [U-95% 15N] REMARK 210 MCL-1-27, 0.4 MM BID_BH3-28, 20 REMARK 210 MM HEPES-29, 1 MM DTT-30, 6 MG/ REMARK 210 ML PF1 PHAGE-31, 90% H2O/10% D2O; REMARK 210 0.4 MM MCL-1-32, 0.4 MM [U-95% REMARK 210 15N] BID_BH3-33, 20 MM HEPES-34, REMARK 210 1 MM DTT-35, 8 MG/ML PF1 PHAGE- REMARK 210 36, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D CBCA(CO)NH; REMARK 210 3D HNCO; 3D HNCA; 3D HNCACB; 3D REMARK 210 1H-15N NOESY; 2D 1H-13C HSQC; 3D REMARK 210 HCCH-COSY; 3D 1H-13C NOESY; 3D REMARK 210 CCH-TOCSY; 3D 1H-15N NOESY REMARK 210 N15C13 FILTERED; 3D 1H-13C NOESY REMARK 210 N15C13 FILTERED; 3D 1H-15N REMARK 210 HETERONUCLEAR NOESY; IPAP-HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 600 MHZ; 500 MHZ REMARK 210 SPECTROMETER MODEL : INOVA; AVANCE REMARK 210 SPECTROMETER MANUFACTURER : VARIAN; BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XWINNMR, VNMRJ, NMRVIEW, TALOS, REMARK 210 CYANA, PROCHECKNMR REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-10 REMARK 465 RES C SSSEQI REMARK 465 THR A 163 REMARK 465 PRO A 164 REMARK 465 PRO A 165 REMARK 465 PRO A 166 REMARK 465 GLY B 72 REMARK 465 PRO B 73 REMARK 465 LEU B 74 REMARK 465 GLY B 75 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLU A 170 -37.05 -179.24 REMARK 500 1 ASP A 195 62.48 -115.16 REMARK 500 1 THR A 196 71.02 -104.07 REMARK 500 1 SER A 202 -60.27 -166.68 REMARK 500 1 LEU A 235 -70.34 -57.59 REMARK 500 1 ASP A 236 109.33 56.82 REMARK 500 1 LYS A 238 -3.50 -144.58 REMARK 500 1 ARG A 310 -23.93 82.15 REMARK 500 1 HIS A 320 125.78 63.97 REMARK 500 1 GLU B 77 154.02 52.43 REMARK 500 1 GLN B 79 -38.79 -39.73 REMARK 500 1 SER B 100 92.12 -167.40 REMARK 500 2 GLU A 168 -66.96 -144.99 REMARK 500 2 LYS A 194 84.85 19.48 REMARK 500 2 LYS A 197 81.44 42.31 REMARK 500 2 PRO A 198 -74.10 -50.42 REMARK 500 2 MET A 199 -169.16 -77.51 REMARK 500 2 GLU A 225 -39.32 -36.66 REMARK 500 2 LEU A 235 -70.86 -58.59 REMARK 500 2 ASP A 236 112.08 59.79 REMARK 500 2 LYS A 238 -27.14 179.78 REMARK 500 2 GLN A 283 58.92 -144.01 REMARK 500 2 ARG A 310 -17.26 75.49 REMARK 500 2 HIS A 320 -74.69 66.28 REMARK 500 2 LEU A 324 176.66 52.63 REMARK 500 2 GLU A 325 102.62 55.40 REMARK 500 2 GLU B 77 -156.02 -127.46 REMARK 500 2 SER B 100 41.68 -177.13 REMARK 500 2 PRO B 103 -169.87 -75.18 REMARK 500 3 GLU A 171 -76.01 -53.04 REMARK 500 3 ARG A 201 -82.06 -152.93 REMARK 500 3 SER A 202 95.76 56.12 REMARK 500 3 LEU A 235 -70.53 -58.10 REMARK 500 3 ASP A 236 112.25 59.49 REMARK 500 3 LYS A 238 -9.92 -141.63 REMARK 500 3 GLN A 283 44.76 -143.85 REMARK 500 3 ARG A 310 -25.45 78.44 REMARK 500 3 ASP A 323 31.71 -149.06 REMARK 500 3 GLU A 325 -62.48 -100.95 REMARK 500 3 GLU B 77 -156.92 -133.83 REMARK 500 3 SER B 100 85.06 -176.16 REMARK 500 3 PRO B 103 60.63 -67.10 REMARK 500 4 GLU A 168 -66.26 68.91 REMARK 500 4 GLU A 169 177.49 -56.94 REMARK 500 4 LYS A 194 74.44 -67.97 REMARK 500 4 SER A 202 66.62 -170.46 REMARK 500 4 LEU A 235 -70.67 -56.83 REMARK 500 4 ASP A 236 109.64 58.04 REMARK 500 4 LYS A 238 -28.84 174.53 REMARK 500 4 ASN A 282 62.98 88.96 REMARK 500 REMARK 500 THIS ENTRY HAS 136 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1WSX RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF FREE MCL-1 DBREF 2KBW A 163 326 UNP Q07820 MCL1_HUMAN 163 326 DBREF 2KBW B 76 106 UNP P55957 BID_HUMAN 76 106 SEQRES 1 A 164 THR PRO PRO PRO ALA GLU GLU GLU GLU ASP GLU LEU TYR SEQRES 2 A 164 ARG GLN SER LEU GLU ILE ILE SER ARG TYR LEU ARG GLU SEQRES 3 A 164 GLN ALA THR GLY ALA LYS ASP THR LYS PRO MET GLY ARG SEQRES 4 A 164 SER GLY ALA THR SER ARG LYS ALA LEU GLU THR LEU ARG SEQRES 5 A 164 ARG VAL GLY ASP GLY VAL GLN ARG ASN HIS GLU THR ALA SEQRES 6 A 164 PHE GLN GLY MET LEU ARG LYS LEU ASP ILE LYS ASN GLU SEQRES 7 A 164 ASP ASP VAL LYS SER LEU SER ARG VAL MET ILE HIS VAL SEQRES 8 A 164 PHE SER ASP GLY VAL THR ASN TRP GLY ARG ILE VAL THR SEQRES 9 A 164 LEU ILE SER PHE GLY ALA PHE VAL ALA LYS HIS LEU LYS SEQRES 10 A 164 THR ILE ASN GLN GLU SER CYS ILE GLU PRO LEU ALA GLU SEQRES 11 A 164 SER ILE THR ASP VAL LEU VAL ARG THR LYS ARG ASP TRP SEQRES 12 A 164 LEU VAL LYS GLN ARG GLY TRP ASP GLY PHE VAL GLU PHE SEQRES 13 A 164 PHE HIS VAL GLU ASP LEU GLU GLY SEQRES 1 B 35 GLY PRO LEU GLY SER GLU SER GLN GLU ASP ILE ILE ARG SEQRES 2 B 35 ASN ILE ALA ARG HIS LEU ALA GLN VAL GLY ASP SER MET SEQRES 3 B 35 ASP ARG SER ILE PRO PRO GLY LEU VAL HELIX 1 1 ASP A 172 GLY A 192 1 21 HELIX 2 2 GLY A 203 HIS A 224 1 22 HELIX 3 3 HIS A 224 ASP A 236 1 13 HELIX 4 4 ASN A 239 ASP A 241 5 3 HELIX 5 5 ASP A 242 SER A 255 1 14 HELIX 6 6 ASN A 260 ILE A 281 1 22 HELIX 7 7 CYS A 286 LYS A 302 1 17 HELIX 8 8 LYS A 302 GLN A 309 1 8 HELIX 9 9 TRP A 312 HIS A 320 1 9 HELIX 10 10 SER B 78 SER B 100 1 23 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1